New York, NY, Dec. 11, 2017 -- There are more than 250,000 women living in the U.S. today who were diagnosed with breast cancer before their 41st birthday. Young breast cancer survivors face a unique set of issues about which healthcare providers need to be informed.
|
|||
Young Survival Coalition® (YSC), the premier organization dedicated to young women affected by breast cancer, is hosting its annual Summit February 23 - 25, 2018, in Orlando, Florida.
As part of the Summit, YSC is proud to offer an educational program series for healthcare providers: “A Different Shade of Pink: A Continuing Education Program About Breast Cancer in Young Women.” The half-day educational seminar will address issues unique to young women, including biological differences of tumors, recent progress in treating young women as well as psychosocial concerns.
Social workers and nurses will receive three Continuing Education (CE) hours. Learn more about this dynamic educational seminar at summit.youngsurvival.org/healthcareproviders.
The YSC Summit will take place February 23 - 25, 2018 at the Renaissance Orlando at Seaworld, in Orlando, Florida. “A Different Shade of Pink” will take place Friday, February 22, and is free of charge, though advanced registration is required.
The YSC Summit offers additional opportunities for education and connection with healthcare providers, speakers and exhibitors. The registration fee is $145 per person until January 1, 2018, and then $175 until February 16. Onsite registration is $200. Fee waivers are available to those who qualify, and fundraising options are available to offset expenses.
Registration is open at summit.youngsurvival.org
For complete registration details, schedule of workshops and speakers, please visit summit.youngsurvival.org or call 877.972.1011.
About Young Survival Coalition (YSC)
Established in 1998, Young Survival Coalition (YSC) is the premier organization dedicated to young women with breast cancer. Founded by three young survivors, YSC began as a grassroots organization to advocate on behalf of all young women diagnosed with breast cancer to increase their length and quality of life. Based in New York City, with networks nationwide, YSC provides free resources, connections and educational materials so young women with breast cancer feel supported, empowered and hopeful. YSC seeks to educate and influence the medical, research and legislative communities to address breast cancer in young women, and to ensure that no young woman faces breast cancer alone. For more information, visit youngsurvival.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4ac588f4-8144-4e6d-8a9f-6e4be9091fc9
Emily Helck Young Survival Coalition 6462573024 [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Anta Sports Expands Global Footprint With Strategic Puma Stake
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



